Commonwealth Equity Services’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Buy
+8,420
New +$254K ﹤0.01% 3788
2026
Q1
Sell
-7,495
Closed -$208K 4318
2025
Q4
$208K Buy
+7,495
New +$191K ﹤0.01% 3956
2024
Q2
Sell
-11,864
Closed -$392K 4053
2024
Q1
$392K Buy
+11,864
New +$370K ﹤0.01% 3031
2023
Q4
Sell
-9,812
Closed -$236K 3914
2023
Q3
$236K Buy
9,812
+1,030
+12% +$27.6K ﹤0.01% 3230
2023
Q2
$280K Buy
8,782
+913
+12% +$29.6K ﹤0.01% 3112
2023
Q1
$240K Buy
+7,869
New +$311K ﹤0.01% 3150
2022
Q4
Sell
-5,070
Closed -$241K 3715
2022
Q3
$241K Sell
5,070
-1,232
-20% -$70.3K ﹤0.01% 3003
2022
Q2
$243K Sell
6,302
-1,896
-23% -$75.4K ﹤0.01% 3019
2022
Q1
$469K Buy
8,198
+1,037
+14% +$68K ﹤0.01% 2575
2021
Q4
$570K Sell
7,161
-613
-8% -$52.5K ﹤0.01% 2415
2021
Q3
$676K Buy
7,774
+478
+7% +$48K ﹤0.01% 2242
2021
Q2
$939K Buy
7,296
+3,567
+96% +$284K ﹤0.01% 1952
2021
Q1
$298K Buy
3,729
+885
+31% +$84.2K ﹤0.01% 2770
2020
Q4
$232K Buy
+2,844
New +$140K ﹤0.01% 2797

Other funds holding BEAM

Commonwealth Equity Services's BEAM Position: Q2 2026 in Review

Commonwealth Equity Services opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 8,420 shares worth $289K. The stake represents ﹤0.01% of the portfolio and ranks #3788 among its holdings. This is a return to the name: Commonwealth Equity Services previously reported a position in BEAM as recently as Q4 2025.

Commonwealth Equity Services first reported a position in BEAM in Q4 2020 and has held it in 14 quarters since. The position peaked at $939K in Q2 2021. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Commonwealth Equity Services held 8,420 shares of Beam Therapeutics worth $289K as of Q2 2026.
  • Beam Therapeutics was a new Commonwealth Equity Services position in Q2 2026.
  • Beam Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3788 holding.
  • Commonwealth Equity Services first reported a position in Beam Therapeutics in Q4 2020 and has held it in 14 quarters since.
  • Commonwealth Equity Services's Beam Therapeutics position peaked at $939K in Q2 2021.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.